CRBP vs. CADL

Last updated Jun 23, 2026

CRBP (Corbus Pharmaceuticals Holdings, Inc.) and CADL (Candel Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, CRBP returned -1.85%/yr vs 86.97%/yr for CADL. At a 0.18 correlation, their price movements are largely independent.

Performance

CRBP vs. CADL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Candel Therapeutics, Inc. (CADL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRBP achieves a 2.09% return, which is significantly lower than CADL's 61.95% return.

CRBP

• 1D: 0.61%
• 1M: -26.78%
• YTD: 2.09%
• 6M: -0.36%
• 1Y: 0.85%
• 3Y*: -1.85%
• 5Y*: -32.59%
• 10Y*: -21.17%

CADL

• 1D: 10.11%
• 1M: 14.52%
• YTD: 61.95%
• 6M: 54.04%
• 1Y: 92.63%
• 3Y*: 86.97%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRBP vs. CADL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CRBP Corbus Pharmaceuticals Holdings, Inc.	2.09%	-31.02%	95.36%	82.20%	-82.05%	-55.71%
CADL Candel Therapeutics, Inc.	61.95%	-34.91%	490.48%	-17.88%	-77.11%	-2.25%

Correlation

The correlation between CRBP and CADL is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.35
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (All Time) Calculated using the full available price history since Jul 27, 2021	0.18

The correlation between CRBP and CADL shifts across timeframes, from 0.18 (all time) to 0.35 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CRBP : $155.45M CADL : $570.61M
EPS CRBP : -$5.98 CADL : -$0.97
PB Ratio CRBP : 1.23 CADL : 4.13
Total Revenue (TTM) CRBP : $0.00 CADL : $0.00
Gross Profit (TTM) CRBP : -$149.00K CADL : -$600.00K
EBITDA (TTM) CRBP : -$61.36M CADL : -$71.64M

Return for Risk

CRBP vs. CADL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRBP

CRBP Risk / Return Rank: 44
CRBP Sharpe Ratio Rank: 43
CRBP Sortino Ratio Rank: 46
CRBP Omega Ratio Rank: 47
CRBP Calmar Ratio Rank: 42
CRBP Martin Ratio Rank: 42

CADL

CADL Risk / Return Rank: 77
CADL Sharpe Ratio Rank: 78
CADL Sortino Ratio Rank: 77
CADL Omega Ratio Rank: 74
CADL Calmar Ratio Rank: 80
CADL Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRBP vs. CADL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and Candel Therapeutics, Inc. (CADL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRBP	CADL	Difference
Sharpe ratio: Return per unit of total volatility	0.01	1.27	-1.26
Sortino ratio: Return per unit of downside risk	0.61	2.07	-1.47
Omega ratio: Gain probability vs. loss probability	1.09	1.25	-0.16
Calmar ratio: Return relative to maximum drawdown	0.01	2.51	-2.50
Martin ratio: Return relative to average drawdown	0.02	4.52	-4.50

CRBP vs. CADL - Sharpe Ratio Comparison

The current CRBP Sharpe Ratio is 0.01, which is lower than the CADL Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of CRBP and CADL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CRBP vs. CADL - Drawdown Comparison

The maximum CRBP drawdown since its inception was -99.31%, which is greater than CADL's maximum drawdown of -94.33%. Use the drawdown chart below to compare losses from any high point for CRBP and CADL.

Drawdown Indicators

	CRBP	CADL	Difference
Max Drawdown Largest peak-to-trough decline	-99.31%	-94.33%	-4.98%
Max Drawdown (1Y) Largest decline over 1 year	-61.88%	-37.04%	-24.84%
Max Drawdown (3Y) Largest decline over 3 years	-92.01%	-72.86%	-19.15%
Max Drawdown (5Y) Largest decline over 5 years	-96.55%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.31%	—	—
Current Drawdown Current decline from peak	-97.32%	-34.64%	-62.68%
Average Drawdown Average peak-to-trough decline	-66.11%	-62.57%	-3.54%
Ulcer Index Depth and duration of drawdowns from previous peaks	41.86%	20.57%	+21.29%

Volatility

CRBP vs. CADL - Volatility Comparison

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a higher volatility of 43.31% compared to Candel Therapeutics, Inc. (CADL) at 18.78%. This indicates that CRBP's price experiences larger fluctuations and is considered to be riskier than CADL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRBP	CADL	Difference
Volatility (1M) Calculated over the trailing 1-month period	43.31%	18.78%	+24.53%
Volatility (6M) Calculated over the trailing 6-month period	60.26%	52.74%	+7.52%
Volatility (1Y) Calculated over the trailing 1-year period	81.71%	73.67%	+8.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	159.23%	166.61%	-7.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	129.12%	166.61%	-37.49%

Dividends

CRBP vs. CADL - Dividend Comparison

Neither CRBP nor CADL has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CRBP and CADL in my portfolio?

CRBP and CADL have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRBP or CADL?

CRBP has higher volatility (43.31%) compared to CADL (18.78%). In terms of maximum drawdown, CRBP dropped -99.31% vs CADL's -94.33%.

Which has better risk-adjusted returns?

CADL currently has the higher Sharpe Ratio (1.27 vs 0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.